Retatrutide is a triple-agonist medication, meaning it activates three hormone receptors involved in appetite and metabolism: GLP-1, GIP, and the glucagon receptor
What the SELECT Trial Mediation Analysis Revealed The most definitive clinical evidence that cardiovascular protection is not driven by weight loss comes from a prespecified analysis of the SELECT trial, which enrolled 17,604 patients with obesity and established cardiovascular disease but no diabetes
Its also essential to be properly hydrated and have adequate electrolyte balance, which a registered dietitian or nutritionist can help you with
Weight Loss Program in Southlake, TXadmin2026-07-20T15:54:26-06:00 Personalized, Guided Weight Loss Plans That Actually Work
Both of these GLP-1 medications are proven to be effective for weight management, but Troy understands that every patients needs are unique
ZP CON BS 25FEB2026 Zepbound, its delivery device base and KwikPen are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates
.webp)
